MedTrace Logo

Clinical Trial of Several Contact Lenses in Extended Wear

NCT00762788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2015-06-29

Study results available
· View outcomes & findings →

Summary

The study is to clinically evaluate currently marketed contact lenses when used in an extended wear modality of up to seven days/six nights.

Conditions

  • Myopia

Interventions

DEVICE

senofilcon A

1 week extended wear contact lens

DEVICE

lotrafilcon A

1 week extended wear contact lens

DEVICE

lotrafilcon B

1 week extended wear contact lens

DEVICE

balafilcon A

1 week extended wear contact lens

DEVICE

comfilcon A

1 week extended wear contact lens

DEVICE

etafilcon A

1 week extended wear contact lens

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762788 on ClinicalTrials.gov